Immunohistochemically, HRS cells in NSCHL are typically positive for CD30 and usually positive for CD15, while lacking expression of CD45, CD20, and CD3 [6–8]. This evidence concerns the gene TNFRSF8 and nodular sclerosis classical Hodgkin lymphoma.